A call to action: Women and peripheral artery disease: A scientific statement from the american heart association

Circulation

Volumn 125, Issue 11, 2012, Pages 1449-1472

  Hirsch, Alan T ^a   Allison, Matthew A ^a   Gomes, Antoinette S ^a   Corriere, Matthew A ^a   Duval, Sue ^a   Ershow, Abby G ^a   Hiatt, William R ^a   Karas, Richard H ^a   Lovell, Marge B ^a   McDermott, Mary M ^a   Mendes, Donna M ^a   Nussmeier, Nancy A ^a   Treat Jacobson, Diane ^a  

^a NONE

Author keywords

AHA Scientific Statements; arteriosclerosis; epidemiology; myocardial infarction; peripheral artery disease; prevention; stroke; women

Indexed keywords

CILOSTAZOL;

ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; COMPRESSION THERAPY; ECONOMIC ASPECT; ENDOVASCULAR SURGERY; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; EVIDENCE BASED PRACTICE; EXERCISE; HEALTH CARE; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LEG REVASCULARIZATION; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SEX DIFFERENCE; WOMEN'S HEALTH;

AMERICAN HEART ASSOCIATION; FEMALE; HUMANS; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; RESEARCH REPORT; UNITED STATES; WOMEN'S HEALTH;

EID: 84858699318     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e31824c39ba     Document Type: Article

References (300)

1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999 -2000. Circulation. 2004;110: 738-743. (Pubitemid 39056275)
2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324. (Pubitemid 33015522)
3. Coni NB, Tennison B, Troup M. Prevalence of lower extremity arterial disease among elderly people in the community. Br J Gen Pract. 1992;42:149-152.
4. Gallotta G, Iazzetta N, Milan G, Ruocco A, Napoli C, Postiglione A. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology. 1997;43:289-295. (Pubitemid 27390310)
5. Cheng S, Ting AC, Lau H, Wong J. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J Surg. 1999;23:202-206. (Pubitemid 29047381)
6. Binaghi F, Fronteddu PF, Cannas F, Caredda E, Uras A, Garau P, Pitzus F. Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population. Int Angiol. 1994; 13:233-245. (Pubitemid 24295724)
7. Al Zahrani HA, Al Bar HM, Bahnassi A, Abdulaal AA. The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. Int Angiol. 1997;16:123-128. (Pubitemid 27353144)
8. Fuster V, Kelly BB, eds; Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: National Academies Press; 2010.
9. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson JD, Steg PG, Bhatt DL; REACH Registry Investigators. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008;1:38-45.
10. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209-215.
11. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, Mohler ER 3rd, Creager MA, Hobson RW 2nd, Robertson RM, Howard WJ, Schroeder P, Criqui MH; Peripheral Arterial Disease Coalition. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation. 2007; 116:2086-2094. (Pubitemid 350023753)
12. Mosca L, Mochari H, Christian A, Berra K, Taubert K, Mills T, Burdick KA, Simpson SL. National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation. 2006;113: 525-534.
13. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation. 2006;113:e463-e654.
14. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 011;124: 2020-2045.
15. Higgins JP, Higgins JA. Epidemiology of peripheral arterial disease in women. J Epidemiol. 2003;13:1-14. (Pubitemid 44137122)
16. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32:328-333. (Pubitemid 46441734)
17. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK; Cardiovascular Heart Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845. (Pubitemid 23263998)
18. McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, Wu C, Homma S, Sharrett AR. Ankle-brachial index and subclinical cardiac and carotid disease: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2005;162:33-41. (Pubitemid 40884998)
19. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L. Prevalence of lower-extremity disease in the US adult population-40 years of age with and without diabetes: 1999 -2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:1591-1597. (Pubitemid 38857431)
20. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515. (Pubitemid 15133809)
21. Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, Gamst A, Bundens WP, Fronek A. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112: 2703-2707. (Pubitemid 41532608)
22. Fabsitz RR, Sidawy AN, Go O, Lee ET, Welty TK, Devereux RB, Howard BV. Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study. Am J Epidemiol. 1999;149:330-338. (Pubitemid 29302105)
23. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM; Ankle Brachial Index Collaboration. Ankle brachial index combined with Fra- mingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197-208. (Pubitemid 351969304)
24. Vavra AK, Kibbe MR. Women and peripheral arterial disease. Womens Health (Lond Engl). 2009;5:669-683.
25. Mosenifar Z. Population issues in clinical trials. Proc Am Thorac Soc. 2007;4:185-187. (Pubitemid 46743316)
26. Kim ES, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol. 2009;29:279-283.
27. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599-1606. (Pubitemid 33010284)
28. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the Women's Health and Aging Study [published correction appears in Circulation. 2001; 104:504]. Circulation. 2000;101:1007-1012. (Pubitemid 30131703)
29. McDermott MM, Greenland P, Liu K, Criqui MH, Guralnik JM, Celic L, Chan C. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc. 2003;51:222-228. (Pubitemid 36205851)
30. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45:1185-1191. (Pubitemid 46817840)
31. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292:453-461. (Pubitemid 38988954)
32. McDermott MM, Guralnik JM, Tian L, Ferrucci L, Liu K, Liao Y, Criqui MH. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol. 2007;50:974-982. (Pubitemid 47334723)
33. Bloemenkamp DG, Mali WP, Tanis BC, van den Bosch MA, Kemmeren JM, Algra A, van der Graaf Y. Functional health and well-being of relatively young women with peripheral arterial disease is decreased but stable after diagnosis. J Vasc Surg. 2003;38:104-110. (Pubitemid 41123296)
34. Collins TC, Suarez-Almazor M, Bush RL, Petersen NJ. Gender and peripheral arterial disease. J Am Board Fam Med. 2006;19:132-140. (Pubitemid 44046975)
35. Gardner AW. Sex differences in claudication pain in subjects with peripheral arterial disease. Med Sci Sports Exerc. 2002;34:1695-1698. (Pubitemid 35283482)
36. Gardner AW, Parker DE, Montgomery PS, Blevins SM, Nael R, Afaq A. Sex differences in calf muscle hemoglobin oxygen saturation in patients with intermittent claudication. J Vasc Surg. 2009;50:77-82.
37. McDermott MM, Ferrucci L, Simonsick EM, Balfour J, Fried L, Ling S, Gibson D, Guralnik JM. The ankle brachial index and change in lower extremity functioning over time: the Women's Health and Aging Study. J Am Geriatr Soc. 2002;50:238-246. (Pubitemid 34132422)
38. McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Kibbe M, Liao Y, Tao H, Criqui MH. Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol 2011;57:707-714.
39. Feinglass J, McDermott MM, Foroohar M, Pearce WH. Gender differences in interventional management of peripheral vascular disease: evidence from a blood flow laboratory population. Ann Vasc Surg. 1994;8:343-349. (Pubitemid 24262602)
40. Amaranto DJ, Abbas F, Krantz S, Pearce WH, Wang E, Kibbe MR. An evaluation of gender and racial disparity in the decision to treat surgically arterial disease. J Vasc Surg. 2009;50:1340-1347.
41. Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC Jr, Wilson PW, Watson KE, Steg PG; REACH Registry Investigators. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Am Heart J. 2009;158:1038-1045.
42. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation. 2009;119:123-130.
43. Lefebvre KM, Metraux S. Disparities in level of amputation among minorities: implications for improved preventative care. J Natl Med Assoc. 2009;101:649-655.
44. Regenbogen SE, Gawande AA, Lipsitz SR, Greenberg CC, Jha AK. Do differences in hospital and surgeon quality explain racial disparities in lower-extremity vascular amputations? Ann Surg. 2009;250:424-431.
45. Robinson WP 3rd, Owens CD, Nguyen LL, Chong TT, Conte MS, Belkin M. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg. 2009;49:1416-1425.
46. Aboyans V, Criqui MH, McClelland RL, Allison MA, McDermott MM, Goff DC Jr, Manolio TA. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg. 2007;45:319-327. (Pubitemid 46149994)
47. Allison MA, Aboyans V, Granston T, McDermott MM, Kamineni A, Ni H, Criqui MH. The relevance of different methods of calculating the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Epidemiol. 2010;171:368-376.
48. Owens MD, Beckles GLA, Ho KK-Y, Gorrell P, Brady J, Kaftarian JS. Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Womens Health (Larchmt). 2008;17:1415-1423.
49. McDermott Tiukinhoy S, Greenland P, Liu K, Pearce WH, Guralnik JM, Unterreiner S, Gluckman TJ, Criqui MH, Ferrucci L. A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication. J Cardiopulm Rehabil. 2004;24:187-196. (Pubitemid 38703112)
50. Nguyen LL, Henry AJ. Disparities in vascular surgery: is it biology or environment? J Vasc Surg. 2010;51(suppl 1):S36-S41.
51. Kroger K, Dragano N, Stang A, Moebus S, Möhlenkamp S, Mann K, Siegrist J, Jöckel KH, Erbel R; Heinz Nixdorf Recall Study Investigator Group. An unequal social distribution of peripheral arterial disease and the possible explanations: results from a population-based study. Vasc Med. 2009;14:289-296.
52. Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg. 2009;50:349-354.
53. Peterson ED, Lytle BL, Biswas MS, Coombs L. Willingness to participate in cardiac trials. Am J Geriatr Cardiol. 2004;13:11-15.
54. Vegda K, Nie JX, Wang L, Tracy CS, Moineddin R, Upshur RE. Trends in health services utilization, medication use, and health conditions among older adults: a 2-year retrospective chart review in a primary care practice. BMC Health Serv Res. 2009;9:217.
55. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA. 2006;295:536-546. (Pubitemid 43200348)
56. Aboyans V, Criqui M, Abraham P, Allison M, Creager MA, Diehm C, Fowkes FG, Hiatt WR, Jonsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande RL, Preux P-M, Stoffers H.E.J.H.J., Treat- Jacobson D. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. In press.
57. Bui BT, Miller S, Mildenberger P, Sam A 2nd, Sheng R; Omniscan MRA Investigator Panel. Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial. J Magn Reson Imaging. 2010;31:1402-1410.
58. Vahl AC, Geselschap J, Montauban van Swijndregt AD, Smit J, Sala J, Turkcan K, Dijksman LM, Visser MJ. Contrast enhanced magnetic resonance angiography versus intra-arterial digital subtraction angiography for treatment planning in patients with peripheral arterial disease: a randomised controlled diagnostic trial. Eur J Vasc Endovasc Surg. 2008;35:514-521. (Pubitemid 351479216)
59. Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology. 2005;235:699-708. (Pubitemid 40571116)
60. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301: 415-424.
61. Kock MC, Adriaensen ME, Pattynama PM, van Sambeek MR, van Urk H, Stijnen T, Hunink MG. DSA versus multi-detector row CT angiography in peripheral arterial disease: randomized controlled trial. Radiology. 2005;237:727-737. (Pubitemid 41507918)
62. Ouwendijk R, Kock MC, Visser K, Pattynama PM, de Haan MW, Hunink MG. Interobserver agreement for the interpretation of contrast- enhanced 3D MR angiography and MDCT angiography in peripheral arterial disease. AJR Am J Roentgenol. 2005;185:1261-1267.
63. AhChong AK, Chiu KM, Wong M, Yip AW. The influence of gender difference on the outcomes of infrainguinal bypass for critical limb ischaemia in Chinese patients. Eur J Vasc Endovasc Surg. 2002;23: 134-139. (Pubitemid 41079476)
64. Dinter DJ, Neff KW, Visciani G, Lachmann R, Weiss C, Schoenberg SO, Michaely HJ. Peripheral bolus-chase MR angiography: analysis of risk factors for nondiagnostic image quality of the calf vessels: a combined retrospective and prospective study. AJR Am J Roentgenol. 2009;193:234-240.
65. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106:388-391.
66. Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg. 1998;27:267-274.
67. Strandness DE Jr, Dalman RL, Panian S, Rendell MS, Comp PC, Zhang P, Forbes WP. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002;36:83-91. (Pubitemid 35278404)
68. Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE Jr, Bortey EB, Forbes WP. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med. 1999;159:2041-2050. (Pubitemid 29453592)
69. Dawson DL, Cutler BS, Meissner MH, Strandness Jr. D.E. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 1998;98:678-686. (Pubitemid 28387495)
70. Elam MB, Heckman J, Crouse JR, Hunninghake DB, Herd JA, Davidson M, Gordon IL, Bortey EB, Forbes WP. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler Thromb Vasc Biol. 1998;18:1942-1947. (Pubitemid 28565758)
71. Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE Jr. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000; 109:523-530.
72. Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects). J Vasc Surg. 2008;47:330 -336.e2.
73. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002;90:1314-1319. (Pubitemid 35449476)
74. Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003748.
75. Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002;50:1939-1946. (Pubitemid 35462438)
76. Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010;15:181-188.
77. Holm J, Dahllöf AG, Björntorp P, Scherstén T. Enzyme studies in muscles of patients with intermittent claudication: effect of training. Scand J Clin Lab Inv. 1973;128:201-205.
78. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg. 1996;11:409-413. (Pubitemid 26192844)
79. Ciuffetti G, Paltriccia R, Lombardini R, Lupattelli G, Pasqualini L, Mannarino E. Treating peripheral arterial occlusive disease: pentoxifylline vs exercise. Int Angiol. 1994;13:33-39. (Pubitemid 24193281)
80. Jones PP, Skinner JS, Smith LK, John FM, Bryant CX. Functional improvements following StairMaster vs. treadmill exercise training for patients with intermittent claudication. J Cardiopulm Rehabil. 1996;16: 47-55. (Pubitemid 26065745)
81. Tew G, Nawaz S, Zwierska I, Saxton JM. Limb-specific and crosstransfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci. 2009;117:405-413.
82. Dahllöf AG, Björntorp P, Holm J, Scherstén T. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Eur J Clin Invest. 1974;4:9-15.
83. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602-609. (Pubitemid 20055969)
84. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, Goldberg AP. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc. 2001;49: 755-762. (Pubitemid 32652468)
85. Crowther RG, Spinks WL, Leicht AS, Sangla K, Quigley F, Golledge J. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg. 2008;47:303-309. (Pubitemid 351172673)
86. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet. 1966;2:1093-1096.
87. Mika P, Spodaryk K, Cencora A, Unnithan VB, Mika A. Experimental model of pain-free treadmill training in patients with claudication. Am J Physical Med Rehab. 2005;84:756-762. (Pubitemid 41416272)
88. Wood RE, Sanderson BE, Askew CD, Walker PJ, Green S, Stewart IB. Effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Clin Sci. 2006;111:401-409. (Pubitemid 44902298)
89. Slrdahl S, Wang E, Hoff J, Kemi OJ, Amundsen BH, Helgerud J. Effective training for patients with intermittent claudication. Scand Cardiovasc J. 2005;39:244-249. (Pubitemid 41358593)
90. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg. 2005;42:702-709. (Pubitemid 41483497)
91. Lundgren F, Dahllöf AG, Lundholm K, Scherstén T, Volkmann R. Intermittent claudication: surgical reconstruction or physical training? Aprospective randomized trial of treatment efficiency. Ann Surg. 1989; 209:346-355. (Pubitemid 19083504)
92. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg. 1990;4:135-140. (Pubitemid 20172197)
93. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg. 2008;48: 1472-1480.
94. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, Chetter IC. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg. 2010;24:69-79.
95. Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur JVasc Endovasc Surg. 1997;14:344-350. (Pubitemid 27511417)
96. Mannarino E, Pasqualini L, Innocente S, Scricciolo V, Rignanese A, Ciuffetti G. Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined? Angiology. 1991;42:513-521.
97. Scheffler P, de la Hamette D, Gross J, Mueller H, Schieffer H. Intensive vascular training in stage IIb of peripheral arterial occlusive disease: the additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training. Circulation. 1994;90:818-822. (Pubitemid 24242750)
98. Arosio E, Minuz P, Prior M, Zuliani V, Gaino S, De Marchi S, Fontana L, Andrioli G, Lechi C, Lechi A. Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease. Life Sci. 2001;69:421-433. (Pubitemid 32539384)
99. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease: implications for the mechanism of the training response. Circulation. 1994;90:1866-1874. (Pubitemid 24320937)
100. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301:165-174.
101. McGuigan MR, Bronks R, Newton RU, Sharman MJ, Graham JC, Cody DV, Kraemer WJ. Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56: B302-B310. (Pubitemid 32645814)
102. Ritti-Dias RM, Wolosker N, de Moraes Forjaz CL, Carvalho CR, Cucato GG, Leaõ PP, de Fátima Nunes Marucci M. Strength training increases walking tolerance in intermittent claudication patients: randomized trial. J Vasc Surg. 2010;51:89-95.
103. Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg. 2006;44:119-127. (Pubitemid 43996880)
104. Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14:203-213.
105. Walker RD, Nawaz S, Wilkinson CH, Saxton JM, Pockley AG, Wood RF. Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication. J Vasc Surg. 2000;31:662-669. (Pubitemid 30214478)
106. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg. 2005;42:1122-1130. (Pubitemid 41817166)
107. Langbein WE, Collins EG, Orebaugh C, Maloney C, Williams KJ, Littooy FN, Edwards LC. Increasing exercise tolerance of persons limited by claudication pain using polestriding. J Vasc Surg. 2002;35: 887-893.
108. Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg. 1997;25:312-318.
109. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology. 1997;48:291-300. (Pubitemid 27172999)
110. Savage P, Ricci MA, Lynn M, Gardner A, Knight S, Brochu M, Ades P. Effects of home versus supervised exercise for patients with intermittent claudication. J Cardiopulm Rehabil. 2001;21:152-157. (Pubitemid 32500054)
111. Cheetham DR, Burgess L, Ellis M, Williams A, Greenhalgh RM, Davies AH. Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial. Eur J Vasc Endovasc Surg. 2004;27:17-23. (Pubitemid 38008988)
112. Tsai JC, Chan P, Wang CH, Jeng C, Hsieh MH, Kao PF, Chen YJ, Liu JC. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med. 2002;252:448-455. (Pubitemid 36706576)
113. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005263.
114. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA. 1995;274: 975-980.
115. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2000;(2):CD000990.
116. Parmenter BJ, Raymond J, Fiatarone Singh MA. The effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials. Sports Med. 2010;40:433-447.
117. Stewart AHR, Lamont PM. Exercise training for claudication. Surgeon. 2008;5:291-299.
118. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000990.
119. Wind J, Koelemay MJ. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication: systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg. 2007;34:1-9. (Pubitemid 46863197)
120. Kakkos SK, Geroulakos G, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2005;30:164-175. (Pubitemid 40932017)
121. Eickhoff JH, Buchardt Hansen HJ, Brommé A, Ericsson BF, Kordt KF, Mouritzen C, Myhre HO, Norgren L, Rostad H, Trippestad A. A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery: preliminary results. Br J Surg. 1983;70: 85-88. (Pubitemid 13180559)
122. Tilanus HW, Obertop H, Van Urk H. Saphenous vein or PTFE for femoropopliteal bypass: a prospective randomized trial. Ann Surg. 1985; 202:780-782. (Pubitemid 16229398)
123. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis: report of a prospective randomized trial in a selected group of patients. J Vasc Surg. 1989; 9:1-9. (Pubitemid 19046488)
124. Arfvidsson B, Lundgren F, Drott C, Scherstén T, Lundholm K. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg. 1990;159:556-560. (Pubitemid 20180120)
125. Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Scherstén T, Stenberg B, Tylén U, Zachrisson BF, Lindberg H, Mattsson E, Persson B, Spangen L, Jonsson E. Chronic lower limb ischaemia: aprospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg. 1991;5:517-522.
126. The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial. Ann Surg. 1994;220:251-266.
127. Bode RH Jr, Lewis KP, Zarich SW, Pierce ET, Roberts M, Kowalchuk GJ, Satwicz PR, Gibbons GW, Hunter JA, Espanola CC. Cardiac outcome after peripheral vascular surgery: comparison of general and regional anesthesia. Anesthesiology. 1996;84:3-13. (Pubitemid 26034417)
128. Christopherson R, Glavan NJ, Norris EJ, Beattie C, Rock P, Frank SM, Gottlieb SO; Perioperative Ischemia Randomized Anesthesia Trial (PIRAT) Study Group. Control of blood pressure and heart rate in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. J Clin Anesth. 1996;8:578-584. (Pubitemid 26347660)
129. Comerota AJ, Weaver FA, Hosking JD, Froehlich J, Folander H, Sussman B, Rosenfield K. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg. 1996;172:105-112. (Pubitemid 26303263)
130. Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD, Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial: the STILE Investigators: Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg. 1996; 24:513-521.
131. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg. 1996;12:167-172. (Pubitemid 26293573)
132. Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, Suggs WD, Hollier L, Money S, Garrett HE; Above-Knee Femoropopliteal Study Group. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. J Vasc Surg. 1997;25:19-28. (Pubitemid 27081605)
133. Pierce ET, Pomposelli FB Jr, Stanley GD, Lewis KP, Cass JL, LoGerfo FW, Gibbons GW, Campbell DR, Freeman DV, Halpern EF, Bode RH Jr. Anesthesia type does not influence early graft patency or limb salvage rates of lower extremity arterial bypass. J Vasc Surg. 1997;25: 226-232.
134. Ross CB, Wheeler WG 2nd, Jones MJ, Kerins CA, Peek TE. Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial. South Med J. 1997;90:16-22. (Pubitemid 27058222)
135. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg. 1997;26:551-557. (Pubitemid 27459599)
136. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, Seeger JM. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg. 1998;28:446-457. (Pubitemid 28421716)
137. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, Mali WP; Dutch Iliac Stent Trial Study Group. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Lancet. 1998;351:1153-1159. (Pubitemid 28171817)
138. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery. 1999;126: 594-601.
139. Hamsho A, Nott D, Harris PL. Prospective randomised trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass. Eur J Vasc Endovasc Surg. 1999;17:197-201. (Pubitemid 29108011)
140. Johnson WC, Lee KK. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions: Veterans Affairs Cooperative Study #141. J Vasc Surg. 1999;30:1077-1083.
141. Tangelder MJ, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC; Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. Quality of life after infrainguinal bypass grafting surgery. J Vasc Surg. 1999;29:913-919. (Pubitemid 29227008)
142. Burger DH, Kappetein AP, Van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg. 2000;32: 278-283. (Pubitemid 30644941)
143. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, Money S, Garrett HE. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg. 2000;31: 417-425. (Pubitemid 30158002)
144. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoralpopliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg. 2000; 32:268-277. (Pubitemid 30644940)
145. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31. (Pubitemid 32097991)
146. Gelin J, Jivegard L, Taft C, Karlsson J, Sullivan M, Dahllöf AG, Sandström R, Arfvidsson B, Lundholm K. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected andomised patients, I: one year results of functional and physiological improvements. Eur J Vasc Endovasc Surg. 2001;22:107-113. (Pubitemid 32737452)
147. Post S, Kraus T, Müller-Reinartz U, Weiss C, Kortmann H, Quentmeier A, Winkler M, Husfeldt KJ, Allenberg JR. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg. 2001;22:226-231. (Pubitemid 32780787)
148. Jackson MR, Johnson WC, Williford WO, Valentine RJ, Clagett GP. The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from amulticenter randomized clinical trial. J Vasc Surg. 2002;35:292-298. (Pubitemid 44718635)
149. Johnson WC, Williford WO; Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg. 2002;35:413-421. (Pubitemid 44718584)
150. Ballotta E, Renon L, Toffano M, Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg. 2003;38:1051-1055. (Pubitemid 37409642)
151. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37:149-155. (Pubitemid 36236959)
152. Robinson BI, Fletcher JP; Australian and New Zealand Femoropopliteal Graft Trial Participants. Fluoropolymer coated Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicentre trial. ANZ J Surg. 2003;73:95-99. (Pubitemid 36513090)
153. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311. (Pubitemid 36314758)
154. Devine C, McCollum C; North West Femoro-Popliteal Trial Participants. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg. 2004;40:924-931. (Pubitemid 39535222)
155. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, Badimon JJ, Fuster V, Corti R. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 2004;110:1156-1161. (Pubitemid 39319016)
156. Smeets L, Ho GH, Tangelder MJ, Algra A, Lawson JA, Eikelboom BC, Moll FL; Dutch BOA Study Group. Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts. Eur J Vasc Endovasc Surg. 2005;30: 604-609. (Pubitemid 41782534)
157. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS; PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742-751.
158. Eiberg JP, Røder O, Stahl-Madsen M, Eldrup N, Qvarfordt P, Laursen A, Greve M, Flörenes T, Nielsen OM, Seidelin C, Vestergaard-Andersen T, Schroeder TV. Fluoropolymer-coated Dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial. Eur J Vasc Endovasc Surg. 2006;32:431-438. (Pubitemid 44362170)
159. Kapfer X, Meichelboeck W, Groegler FM. Comparison of carbonimpregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study. Eur JVasc Endovasc Surg. 2006;32:155-168. (Pubitemid 44089403)
160. Koppensteiner R, Spring S, Amann-Vesti BR, Meier T, Pfammatter T, Rousson V, Banyai M, van der Loo B. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. J Vasc Surg. 2006;44:1247-1253. (Pubitemid 44834599)
161. Raghunathan A, Rapp JH, Littooy F, Santilli S, Krupski WC, Ward HB, Thottapurathu L, Moritz T, McFalls EO; CARP Investigators. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. J Vasc Surg. 2006;43:1175-1182. (Pubitemid 43825662)
162. Rand T, Basile A, Cejna M, Fleischmann D, Funovics M, Gschwendtner M, Haumer M, Von Katzler I, Kettenbach J, Lomoschitz F, Luft C, Minar E, Schneider B, Schoder M, Lammer J. PTA versus carbofilmcoated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol. 2006;29:29-38. (Pubitemid 43128136)
163. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
164. Berceli SA, Hevelone ND, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg. 2007;46:1173-1179.
165. Jensen LP, Lepäntalo M, Fossdal JE, Røder OC, Jensen BS, Madsen MS, Grenager O, Fasting H, Myhre HO, Baekgaard N, Nielsen OM, Helgstrand U, Schroeder TV. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study. Eur J Vasc Endovasc Surg. 2007;34:44-49. (Pubitemid 46863199)
166. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007;45:10-16. (Pubitemid 46038657)
167. Maslow AD, Bert A, Slaiby J, Carney W, Marcaccio E. The effects of vasoactive agents on flow through saphenous vein grafts during lowerextremity peripheral vascular surgery. J Cardiothorac Vasc Anesth. 2007;21:344-350. (Pubitemid 46829894)
168. Nguyen LL, Brahmanandam S, Bandyk DF, Belkin M, Clowes AW, Moneta GL, Conte MS. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg. 2007;46:1191-1197.
169. Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD: results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vasc Med. 2007;12:275-283.
170. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180-1190. (Pubitemid 350267083)
171. Amighi J, Schillinger M, Dick P, Schlager O, Sabeti S, Mlekusch W, Haumer M, Mathies R, Heinzle G, Schuster A, Loewe C, Koppensteiner R, Lammer J, Minar E, Cejna M. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates: randomized controlled trial. Radiology. 2008;247:267-272.
172. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, Thompson SG; MIMIC Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008;36:680-688.
173. Kälsch HI, Eggebrecht H, Mayringer S, Konorza T, Sievers B, Sack S, Erbel R, Kroeger K. Randomized comparison of effects of suture-based and collagen-based vascular closure devices on post-procedural leg perfusion. Clin Res Cardiol. 2008;97:43-48.
174. Ricco JB, Probst H; French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008; 47:45-53.
175. Zeller T, Krankenberg H, Steinkamp H, Rastan A, Sixt S, Schmidt A, Sievert H, Minar E, Bosiers M, Peeters P, Balzer JO, Gray W, Tübler T, Wissgott C, Schwarzwälder U, Scheinert D. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the Multicenter Pathway PVD Trial. J Endovasc Ther. 2009;16:653-662.
176. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009;74:1090-1095.
177. Gisbertz SS, Ramzan M, Tutein Nolthenius RP, van der Laan L, Overtoom TT, Moll FL, de Vries JP. Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery [the REVAS trial]. Eur J Vasc Endovasc Surg. 2009;37:68-76.
178. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49:109 -115, 116.e1-9.
179. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training: randomized controlled trial [published correction appears in Radiology. 2010;256:1016]. Radiology. 2009;250:586-595.
180. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338. (Pubitemid 40354849)
181. van Det RJ, Vriens BH, van der Palen J, Geelkerken RH. Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial. Eur J Vasc Endovasc Surg. 2009;37:457-463.
182. Laurila K, Lepäntalo M, Teittinen K, Kantonen I, Forssell C, Vilkko P, Nielsen OM, Railo M, Lehtola A; ScanPAC Study Group. Does an adjuvant AV-fistula improve the patency of a femorocrural PTFE bypass with distal vein cuff in critical leg ischaemia? A prospective randomised multicentre trial. Eur J Vasc Endovasc Surg. 2004;27:180-185. (Pubitemid 38111686)
183. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H; BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366: 1925-1934. (Pubitemid 41713982)
184. Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK, Scher LA, Samson RH, Towne JB. Randomization of autogenous vein and polytetrafluoroethylene grafts in femoral-distal reconstruction. Surgery. 1982;92:921-930. (Pubitemid 13083912)
185. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, Towne JB, Bernhard VM, Bonier P, Flinn WR, Astelford P, Yao JST, Bergan JJ. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104-114. (Pubitemid 16186498)
186. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487-494. (Pubitemid 36350887)
187. Bosch JL, van der Graaf Y, Hunink MG; for the Dutch Iliac Stent Trial Study Group. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. Circulation. 1999;99:3155-3160. (Pubitemid 29289081)
188. Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum o, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ. The Oslo Balloon Angioplasty versus Conservative Treatment study (OBACT): the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12. (Pubitemid 44856515)
189. Arvela E, Kauhanen P, Albäck A, Lepäntalo M, Neufang A, Adili F, Schmitz-Rixen T; ProVena Study Group. Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts. Eur J Vasc Endovasc Surg. 2009;38:456-462.
190. Bosiers M, Deloose K, Verbist J, Schroë H, Lauwers G, Lansink W, Peeters P. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg. 2006;43:313-318. (Pubitemid 43221926)
191. Brochado-Neto FC, Albers M, Pereira CA, Gonzalez J, Cinelli M Jr. Prospective comparison of arm veins and greater saphenous veins as infrageniculate bypass grafts. Eur J Vasc Endovasc Surg. 2001;22: 146-151. (Pubitemid 32737458)
192. Brosi P, Dick F, Do DD, Schmidli J, Baumgartner I, Diehm N. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg. 2007;46:1198-1207.
193. Canaud L, Alric P, Berthet JP, Marty-Ané C, Mercier G, Branchereau P. Infrainguinal cutting balloon angioplasty in de novo arterial lesions. J Vasc Surg. 2008;48:1182-1188.
194. Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg. 2009;50:542-547.
195. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg. 2000;31(pt 1):93-103. (Pubitemid 30067306)
196. Goodney PP, Nolan BW, Schanzer A, Eldrup-Jorgensen J, Bertges DJ, Stanley AC, Stone DH, Walsh DB, Powell RJ, Likosky DS, Cronenwett JL; Vascular Study Group of Northern New England. Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg. 2010;24:57-68.
197. Goodney PP, Nolan BW, Schanzer A, Eldrup-Jorgensen J, Stanley AC, Stone DH, Likosky DS, Cronenwett JL; Vascular Study Group of Northern New England. Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg. 2010;51: 71-78.
198. Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51: 1967-1974. (Pubitemid 351636450)
199. Jahnke T, Andresen R, Müller-Hülsbeck S, Schäfer FK, Voshage G, Heller M, Brossmann J. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41-51. (Pubitemid 36134073)
200. Klevsgard R, Risberg BO, Thomsen MB, Hallberg IR. A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. J Vasc Surg. 2001;33:114-122. (Pubitemid 32109614)
201. Knight JS, Smeets L, Morris GE, Moll FL. Multi centre study to assess the feasibility of a new covered stent and delivery system in combination with remote superficial femoral artery endarterectomy (RSFAE). Eur J Vasc Endovasc Surg. 2005;29:287-294. (Pubitemid 40267969)
202. Lam RC, Shah S, Faries PL, McKinsey JF, Kent KC, Morrissey NJ. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg. 2007;46:1155-1159. (Pubitemid 350267070)
203. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol. 1998;21: 361-366. (Pubitemid 28452430)
204. Mlekusch W, Haumer M, Mlekusch I, Dick P, Steiner-Boeker S, Bartok A, Sabeti S, Exner M, Wagner O, Minar E, Schillinger M. Prediction of iatrogenic pseudoaneurysm after percutaneous endovascular procedures. Radiology. 2006;240:597-602. (Pubitemid 44098660)
205. Rocha-Singh KJ, Rutherford J. Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trial. Catheter Cardiovasc Interv. 2005;66:470-473. (Pubitemid 41779009)
206. Ruckert RI, Tsilimparis N, Lobenstein B, Witte J, Seip G, Storck M. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study. J Vasc Surg. 2009;49:1203-1209.e3.
207. Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, Conte MS; Vascular Study Group of Northern New England. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg. 2009;50:769-775.
208. Shammas NW, Shammas GA, Jerin M, Dippel EJ, Shammas AN. In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry. J Endovasc Ther. 2010;17:31-36.
209. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, Tsolakis J. Infrapopliteal application of sirolimuseluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-1150.
210. Söderström M, Aho PS, Lepäntalo M, Albäck A. The influence of the characteristics of ischemic tissue lesions on ulcer healing time after infrainguinal bypass for critical leg ischemia. J Vasc Surg. 2009;49: 932-937.
211. Toogood GJ, Torrie EP, Magee TR, Galland RB. Early experience with stenting for iliac occlusive disease. Eur J Vasc Endovasc Surg. 1998; 15:165-168. (Pubitemid 28142861)
212. Wagner HJ, Schmitz R, Alfke H, Klose KJ. Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease. Radiology. 2003;226: 791-797. (Pubitemid 36259157)
213. Wann-Hansson C, Hallberg IR, Risberg B, Lundell A, Klevsgard R. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up. J Adv Nurs. 2005;51: 227-235. (Pubitemid 41059846)
214. Zeller T, Rastan A, Schwarzwälder U, Frank U, Bürgelin K, Amantea P, Müller C, Flügel PC, Neumann FJ. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther. 2004;11: 676-685. (Pubitemid 40110745)
215. Zeller T, Rastan A, Sixt S, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Müller C, Rothenpieler U, Flügel PC, Tepe G, Neumann FJ. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006;48:1573-1578. (Pubitemid 44528188)
216. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation. 2001;104:2057-2062. (Pubitemid 33027046)
217. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori): the Study Group of Critical Chronic Ischemia of the Lower Extremities. Long-term mortality and its predictors in patients with critical leg ischaemia. Eur J Vasc Endovasc Surg. 1997;14:91-95.
218. Albertini JN, Barral X, Branchereau A, Favre JP, Guidicelli H, Magne JL, Magnan PE. Long-term results of arterial allograft below-knee bypass grafts for limb salvage: a retrospective multicenter study. J Vasc Surg. 2000;31:426-435. (Pubitemid 30158003)
219. Al-Khoury G, Marone L, Chaer R, Rhee R, Cho J, Leers S, Makaroun M, Gupta N. Isolated femoral endarterectomy: impact of SFA TASC classification on recurrence of symptoms and need for additional intervention. J Vasc Surg. 2009;50:784-789.
220. Bakken AM, Protack CD, Saad WE, Hart JP, Rhodes JM, Waldman DL, Davies MG. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions. Ann Vasc Surg. 2009;23: 560-568.
221. Ballard JL, Bergan JJ, Singh P, Yonemoto H, Killeen JD. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg. 1998;28:94-101.
222. Ballotta E, Da Giau G, Gruppo M, Mazzalai F, Martella B, Militello C, Toniato A. Revascularization to an isolated ("blind") popliteal artery segment: a viable procedure for critical limb ischemia. Surgery. 2009; 145:426-434.
223. Bannazadeh M, Sarac TP, Bena J, Srivastava S, Ouriel K, Clair D. Reoperative lower extremity revascularization with cadaver vein for limb salvage. Ann Vasc Surg. 2009;23:24-31.
224. Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD. The impact of gender on the results of arterial bypass with in situ greater saphenous vein. Am J Surg. 1995;170:97-102.
225. Berglund J, Björck M, Elfström J; SWEDVASC Femoro-popliteal Study Group. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg. 2005;29:412-418. (Pubitemid 40331378)
226. Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular. 2009;17:1-8.
227. Bruni KR, Bagramian A, Cullen C, Rossi M, Shah DM, Darling RC 3rd, McKee J. Outcome after distal vascular reconstruction in women. J Vasc Nurs. 1999;17:29-31.
228. Chiesa R, Marone EM, Tshomba Y, Logaldo D, Castellano R, Melissano G. Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease. Ann Vasc Surg. 2009;23:764-769.
229. Conte MS. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg. 2009;22:227-233.
230. Costanza MJ, Aueral LA, Lilly MP, Finn WR. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg. 2004;39: 343-350. (Pubitemid 38174316)
231. Cull DL, Langan EM, Gray BH, Johnson B, Taylor SM. Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg. 2010;210:555-561.
232. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg. 2008;48:619-625.
233. De Luccia N, Brochado-Neto FC, Romiti M, Kikuchi M, dos Reis JM, Durazzo AE, Albers MT. Preferential use of nonreversed vein grafts in above-knee femoropopliteal bypasses for critical ischemia: midterm outcome. Ann Vasc Surg. 2008;22:668-675.
234. DeRubertis BG, Vouyouka A, Rhee SJ, Califano J, Karwowski J, Angle N, Faries PL, Kent KC. Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg. 2008;48:150-157.
235. Dosluoglu HH, Lall P, Cherr GS, Harris LM, Dryjski ML. Superior limb salvage with endovascular therapy in octogenarians with critical limb ischemia. J Vasc Surg. 2009;50:305-315,316.e1-2.
236. Dosluoglu HH, Lall P, Nader ND, Harris LM, Dryjski ML. Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia. J Vasc Surg. 2010;51:1178-1189.
237. Eagleton MJ, Ouriel K, Shortell C, Green RM. Femoral-infrapopliteal bypass with prosthetic grafts. Surgery. 1999;126:759-764.
238. Feinglass J, Sohn MW, Rodriguez H, Martin GJ, Pearce WH. Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, 1996-1999, with follow-up through 2004. J Vasc Surg. 2009;50:776 -783.e1.
239. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol. 2004; 44:2307-2314. (Pubitemid 39647603)
240. Flu HC, Lardenoye JH, Veen EJ, Van Berge Henegouwen DP, Hamming JF. Functional status as a prognostic factor for primary revascularization for critical limb ischemia. J Vasc Surg. 2010;51: 360-371.e1.
241. Frangos SG, Karimi S, Kerstein MD, Harpavat M, Sumpio B, Roberts AB, Gahtan V. Gender does not impact infrainguinal vein bypass graft outcome. Surgery. 2000;127:679-686. (Pubitemid 30399060)
242. Giles KA, Pomposelli FB, Spence TL, Hamdan AD, Blattman SB, Panossian H, Schermerhorn ML. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs [published correction appears in J Vasc Surg. 2009;50:1249]. J Vasc Surg. 2008;48:128-136.
243. Graziani L, Silvestro A, Bertone V, Manara E, Alicandri A, Parrinello G, Manganoni A. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant. 2007;22:1144-1149. (Pubitemid 46523430)
244. Hultgren R, Olofsson P, Wahlberg E. Gender differences in vascular interventions for lower limb ischaemia. Eur J Vasc Endovasc Surg. 2001;21:22-27. (Pubitemid 32186292)
245. Hultgren R, Olofsson P, Wahlberg E. Sex-related differences in outcome after vascular interventions for lower limb ischemia. J Vasc Surg. 2002;35:510-516. (Pubitemid 44718596)
246. Hultgren R, Olofsson P, Wahlberg E. Gender differences in patients treated for critical limb ischemia. Eur J Vasc Endovasc Surg. 2005;29: 295-300. (Pubitemid 40267970)
247. Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills Sr. J.L. Sr, Goshima KR,
248. Kandzari DE, Kiesz RS, Allie D, Walker C, Fail P, Ramaiah VG, Cardenas J, Vale J, Chopra A, Gammon RS. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther. 2006;13:12-22. (Pubitemid 43271478)
249. Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48:872-877.
250. Kantonen I, Lepäntalo M, Luther M, Salenius P, Ylönen K; Finnvasc Study Group. Factors affecting the results of surgery for chronic critical leg ischemia: a nationwide survey. J Vasc Surg. 1998;27:940-947. (Pubitemid 28394440)
251. Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O'Hara PJ, Lyden SP, Clair DG. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48: 1451-7,1457.e1- e3.
252. Kechagias A, Perälä J, Ylönen K, Mahar MA, Biancari F. Validation of the Finnvasc score in infrainguinal percutaneous transluminal angioplasty for critical lower limb ischemia. Ann Vasc Surg. 2008;22: 547-551.
253. Keeling AN, Khalidi K, Leong S, Given MF, McGrath FP, Athanasiou T, Lee MJ. Subintimal angioplasty: predictors of long-term success. J Vasc Interv Radiol. 2009;20:1013-1022.
254. Keeling AN, Naughton PA, Khalidi K, Ayyoub AS, Kelly CK, Leahy AL, Bouchier-Hayes DJ, Athanasiou T, Lee MJ. Should incidental asymptomatic angiographic stenoses and occlusions be treated in patients with peripheral arterial disease? J Vasc Interv Radiol. 2009;20: 1133-1140.
255. Laurila K, Luther M, Roth WD, Vilkko P, Kantonen I, Teittinen K, Sihvo EI, Ihlberg L, Albäck A, Lepäntalo M. Adjuvant arteriovenous fistula as means of rescue for infrapopliteal venous bypass with poor runoff. J Vasc Surg. 2006;44:985-991. (Pubitemid 46127453)
256. Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, Bertoglio C, Troiani R, Cao P. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg. 2007;45:32-39. (Pubitemid 46038649)
257. Malmstedt J, Leander K, Wahlberg E, Karlström L, Alfredsson L, Swedenborg J. Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care. 2008;31:887-892.
258. Mays BW, Towne JB, Fitzpatrick CM, Smart SC, Cambria RA, Seabrook GR, Freischlag JA. Women have increased risk of perioperative myocardial infarction and higher long-term mortality rates after lower extremity arterial bypass grafting. J Vasc Surg. 1999;29:807-812.
259. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg. 1998;28:1066-1071. (Pubitemid 28562711)
260. Pulli R, Dorigo W, Castelli P, Dorrucci V, Ferilli F, De Blasis G, Monaca V, Vecchiati E, Pratesi C; Propaten Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg. 2010;51:1167-1177.e1.
261. Randon C, Jacobs B, De Ryck F, Beele H, Vermassen F. Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vasc Surg. 2010;51:869-877.
262. Roddy SP, Darling RC 3rd, Maharaj D, Chang BB, Paty PS, Kreienberg PB, Lloyd WE, Ozsvath K, Shah DM. Gender-related differences in outcome: an analysis of 5880 infrainguinal arterial reconstructions. J Vasc Surg. 2003;37:399-402. (Pubitemid 36240255)
263. Rosenthal D, Schubart PJ, Kinney EV, Martin JD, Sharma R, Matsuura JH, Clark MD. Remote superficial femoral artery endarterectomy: multicenter medium-term results. J Vasc Surg. 2001;34:428-432.
264. Rueda CA, Nehler MR, Perry DJ, McLafferty RB, Casserly IP, Hiatt WR, Peyton BD. Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design. J Vasc Surg. 2008;47:995-999.
265. Sadek M, Ellozy SH, Turnbull IC, Lookstein RA, Marin ML, Faries PL. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg. 2009;49:638-643.
266. Salas CA, Adam DJ, Papavassiliou VG, London NJ. Percutaneous transluminal angioplasty for critical limb ischaemia in octogenarians and nonagenarians. Eur J Vasc Endovasc Surg. 2004;28:142-145. (Pubitemid 38967267)
267. Schmieder GC, Richardson AI, Scott EC, Stokes GK, Meier GH 3rd, Panneton JM. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. J Vasc Surg. 2008;48:1175-1180.
268. Scott EC, Biuckians A, Light RE, Burgess J, Meier GH 3rd, Panneton JM. Subintimal angioplasty: our experience in the treatment of 506 infrainguinal arterial occlusions. J Vasc Surg. 2008;48:878-884.
269. Semaan E, Hamburg N, Nasr W, Shaw P, Eberhardt R, Woodson J, Doros G, Rybin D, Farber A. Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2010;44:25-31.
270. Setacci C, Chisci E, de Donato G, Setacci F, Iacoponi F, Galzerano G. Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg. 2009;38:76-87.
271. Shah AP, Klein AJ, Sterrett A, Messenger JC, Albert S, Nehler MR, Hiatt WR, Casserly IP. Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a Veterans Affairs population with critical limb ischemia. Catheter Cardiovasc Interv. 2009;74:11-19.
272. Taylor SM, Cull DL, Kalbaugh CA, Senter HF, Langan EM 3rd, Carsten CG 3rd, York JW, Snyder BA, Gray BH, Androes MP, Blackhurst DW. Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2,240 limb revascularizations. J Am Coll Surg. 2009;208:770-778.
273. Wall ML, Davies RS, Sykes TC, Guy AJ, Saleem J, Khera G, Simms MH. Iliofemoral pulsion endarterectomy. Ann Vasc Surg. 2009;23: 259-263.
274. Watelet J, Soury P, Menard JF, Plissonnier D, Peillon C, Lestrat JP, Testart J. Femoropopliteal bypass: in situ or reversed vein grafts? Ten-year results of a randomized prospective study. Ann Vasc Surg. 1997;11:510-519. (Pubitemid 27402630)
275. Werneck CC, Lindsay TF. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg. 2009;23:554-559.
276. Wolfle KD, Bruijnen H, Loeprecht H, Rümenapf G, Schweiger H, Grabitz K, Sandmann W, Lauterjung L, Largiader J, Erasmi H, Kasprzak PM, Raithel D, Allenberg JR, Lauber A, Berlakovich GM, Kretschmer G, Hepp W, Becker HM, Schulz A. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg. 2003;25:229-234. (Pubitemid 36527616)
277. Egorova N, Vouyouka AG, Quin J, Guillerme S, Moskowitz A, Marin M, Faries PL. Analysis of gender-related differences in lower extremity peripheral arterial disease. J Vasc Surg. 2010;51:372-378.e1.
278. Magnant JG, Cronenwett JL, Walsh DB, Schneider JR, Besso SR, Zwolak RM. Surgical treatment of infrainguinal arterial occlusive disease in women. J Vasc Surg. 1993;17:67-76.
279. Ballotta E, Da Giau G, Gruppo M, Mazzalai F, Martella B. Infrapopliteal arterial revascularization for critical limb ischemia: is the peroneal artery at the distal third a suitable outflow vessel? J Vasc Surg. 2008;47: 952-959.
280. Harris EJ Jr, Taylor LM Jr, Moneta GL, Porter JM. Outcome of infrainguinal arterial reconstruction in women. J Vasc Surg. 1993;18:627-634
281. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL; PREVENT III Investigators. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006;44:977-983. (Pubitemid 46107228)
282. Morgan RH, Carolan G, Psaila JV, Gardner AMN, Fox RH, Woodcock JP. Arterial flow enhancement by impulse compression. Vasc Endovascular Surg. 1991;25:8-16.
283. Delis KT, Husmann MJ, Cheshhire NJ, Nicolaides AN. Effects of intermittent pneumatic compression of the calf and thigh on arterial calf inflow: a study of normals, claudicants, and grafted arteriopaths. Surgery. 2001;129:188-195.
284. Delis KT, Husmann MJ, Nicolaides AN, Wolfe JH, Cheshire NJ. Enhancing foot skin blood flux in peripheral vascular disease using intermittent pneumatic compression: controlled study on claudicants and grafted arteriopaths. World J Surg. 2002;26:861-866. (Pubitemid 36920330)
285. Delis KT, Labropoulos N, Nicolaides AN, Glenville B, Stansby G.Effect of intermittent pneumatic foot compression on popliteal artery haemodynamics. Eur J Vasc Endovasc Surg. 2000;19:270-277. (Pubitemid 30364837)
286. Gaskell P, Parrott JC. The effect of a mechanical venous pump on the circulation of the feet in the presence of arterial obstruction. Surg Gynecol Obstet. 1978;146:583-592. (Pubitemid 8341217)
287. Labropoulos N, Leon LR Jr, Bhatti A, Melton S, Kang SS, Mansour AM, Borge M. Hemodynamic effects of intermittent pneumatic com- pression in patients with critical limb ischemia. J Vasc Surg. 2005;42: 710-716. (Pubitemid 41483498)
288. Eze AR, Comerota AJ, Cisek PL, Holland BS, Kerr RP, Veeramasuneni R, Comerota AJ Jr. Intermittent calf and foot compression increases lower extremity blood flow. Am J Surg. 1996;172:130-134.
289. Kavros SJ, Delis KT, Turner NS, Voll AE, Liedl DA, Gloviczki P, Rooke TW. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg. 2008;47:543-549. (Pubitemid 351258280)
290. Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-up. Ann Surg. 2005;241:431-441. (Pubitemid 40299719)
291. Delis KT, Nicolaides AN, Wolfe JH, Stansby G. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg. 2000; 31:650-661. (Pubitemid 30214477)
292. Homko CJ, Santamore WP, Zamora L, Shirk G, Gaughan J, Cross R, Kashem A, Petersen S, Bove AA. Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease. J Cardiovasc Nurs. 2008;23:332-337.
293. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN; American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med. 2000;9:506-515.
294. Ferris A, Robertson RM, Fabunmi R, Mosca L. American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation. 2005;111:1321-1326. (Pubitemid 40389098)
295. Lovell M, H.K. Forbes T, Twillman G, Abramson B, Criqui MH, Schroeder P, Mohler ER 3rd, Hirsch AT; Peripheral Arterial Disease Coalition. Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol. 2009; 25:39-45.
296. Bush RL, Kallen MA, Liles DR, Bates JT, Petersen LA. Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease. J Surg Res. 2008;145:313-319.
297. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
298. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pinã IL, Roger VL, Shaw LJ, Zhao D; Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association [published correction appears in Circulation. 2011;123:e624 and in Circulation. 2011;124:e427]. Circulation. 2011;123:1243-1262.
299. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [published correction appears in Circulation. 2004;110:763]. Circulation. 2004;110:227-239. (Pubitemid 38924592)
300. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:2748-2764.